| Michael Andrew Kavanagh, MD | |
|
224-d Cornwall Street, Nw, Suite 204, Leesburg, VA 20176-2700 | |
| (703) 777-3262 | |
| (703) 777-3365 |
| Full Name | Michael Andrew Kavanagh |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 44 Years |
| Location | 224-d Cornwall Street, Nw, Suite 204, Leesburg, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588655740 | NPI | - | NPPES |
| 30016734840001 | Medicaid | VA | |
| 1588655740 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 0101037999 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Loudoun Hospital | Leesburg, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Loudoun Medical Group, Pc | 0042119661 | 280 |
| Loudoun Medical Group, Pc | 0042119661 | 280 |
News Archive
GE Healthcare signed an agreement with Affibody AB to collaborate on the development of a Her2-targeted PET imaging agent, which is scheduled to begin clinical trials later this year.
Rates of death and disability stemming from ear, nose and throat conditions continue to rise in developing countries like Uganda, but despite the need, fewer than 15 operating ear, nose and throat surgeons serve Uganda's 33.4 million and growing population. Only two ENT residency programs exist in this country, but many trainees do not remain in the country after graduation. Mass. Eye and Ear's Office of Global Surgery and Health is launching a new collaboration with Mbarara University Science and Technology School of Medicine and Mbarara Regional Referral Hospital to help address the need for more trained physicians to care for the ENT diseases and conditions of this population and to help encourage those who are ENT trained to stay in the country to care for those who need them.
A compound that accumulates in cells more readily than a commonly used colorectal cancer drug may be just as useful in treating colorectal tumors, but with fewer side effects, MIT researchers have found.
Tengion, Inc., a regenerative medicine company focused on discovering, developing, manufacturing and commercializing neo-organs and neo-tissues, today announced the completion of its initial public offering of 6,000,000 shares of common stock at a price of $5.00 per share. The net proceeds of the offering to Tengion, after deducting underwriting discounts and commissions and estimated offering expenses payable by Tengion, were approximately $26.0 million.
› Verified 9 days ago
| Entity Name | Loudoun Medical Group, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679591440 PECOS PAC ID: 0042119661 Enrollment ID: O20041115000474 |
News Archive
GE Healthcare signed an agreement with Affibody AB to collaborate on the development of a Her2-targeted PET imaging agent, which is scheduled to begin clinical trials later this year.
Rates of death and disability stemming from ear, nose and throat conditions continue to rise in developing countries like Uganda, but despite the need, fewer than 15 operating ear, nose and throat surgeons serve Uganda's 33.4 million and growing population. Only two ENT residency programs exist in this country, but many trainees do not remain in the country after graduation. Mass. Eye and Ear's Office of Global Surgery and Health is launching a new collaboration with Mbarara University Science and Technology School of Medicine and Mbarara Regional Referral Hospital to help address the need for more trained physicians to care for the ENT diseases and conditions of this population and to help encourage those who are ENT trained to stay in the country to care for those who need them.
A compound that accumulates in cells more readily than a commonly used colorectal cancer drug may be just as useful in treating colorectal tumors, but with fewer side effects, MIT researchers have found.
Tengion, Inc., a regenerative medicine company focused on discovering, developing, manufacturing and commercializing neo-organs and neo-tissues, today announced the completion of its initial public offering of 6,000,000 shares of common stock at a price of $5.00 per share. The net proceeds of the offering to Tengion, after deducting underwriting discounts and commissions and estimated offering expenses payable by Tengion, were approximately $26.0 million.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Andrew Kavanagh, MD 224d Cornwall St Nw Ste 403, Leesburg, VA 20176-2704 Ph: (703) 737-6010 | Michael Andrew Kavanagh, MD 224-d Cornwall Street, Nw, Suite 204, Leesburg, VA 20176-2700 Ph: (703) 777-3262 |
News Archive
GE Healthcare signed an agreement with Affibody AB to collaborate on the development of a Her2-targeted PET imaging agent, which is scheduled to begin clinical trials later this year.
Rates of death and disability stemming from ear, nose and throat conditions continue to rise in developing countries like Uganda, but despite the need, fewer than 15 operating ear, nose and throat surgeons serve Uganda's 33.4 million and growing population. Only two ENT residency programs exist in this country, but many trainees do not remain in the country after graduation. Mass. Eye and Ear's Office of Global Surgery and Health is launching a new collaboration with Mbarara University Science and Technology School of Medicine and Mbarara Regional Referral Hospital to help address the need for more trained physicians to care for the ENT diseases and conditions of this population and to help encourage those who are ENT trained to stay in the country to care for those who need them.
A compound that accumulates in cells more readily than a commonly used colorectal cancer drug may be just as useful in treating colorectal tumors, but with fewer side effects, MIT researchers have found.
Tengion, Inc., a regenerative medicine company focused on discovering, developing, manufacturing and commercializing neo-organs and neo-tissues, today announced the completion of its initial public offering of 6,000,000 shares of common stock at a price of $5.00 per share. The net proceeds of the offering to Tengion, after deducting underwriting discounts and commissions and estimated offering expenses payable by Tengion, were approximately $26.0 million.
› Verified 9 days ago
Dr. Nauman J Akhtar, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 224-d Cornwall Street Nw, Suite 204, Leesburg, VA 20176 Phone: 703-777-3262 Fax: 703-777-3365 | |
Matthew Bernard Gavin, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 224-d Cornwall Street, Nw, Suite 204,, Leesburg, VA 20176 Phone: 703-777-3262 Fax: 703-777-3365 | |
Raymond Francis Lower, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 19465 Deerfield Ave Ste 405, Leesburg, VA 20176 Phone: 703-858-1800 Fax: 703-858-1801 | |
Dr. Abdurrahman Kandil, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 224-d Cornwall Street, Nw, Suite 204,, Leesburg, VA 20176 Phone: 703-665-2720 Fax: 703-665-2487 | |
Dr. Ali Moshirfar, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 19450 Deerfield Ave Ste 300, Leesburg, VA 20176 Phone: 703-723-6774 Fax: 703-723-1494 | |
Dr. James Ticknor Gable, DO Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 224 D Cornwall Street Nw, Suite 204, Leesburg, VA 20176 Phone: 703-777-3262 Fax: 703-777-3365 |